ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Booming Profits Despite Drug Price Control

Booming Profits Despite Drug Price Control Hansavivek RANBAXY LABORATORIES has fared so well during 1979 that the directors have decided to offer free shares to the shareholders on a one-for-one basis besides maintaining dividend at 12 per cent. Sales, profits and margins are all higher compared to their respective figures of the previous year. Net profit is more than 50 per cent better and the distribution is covered 7.12 times by earnings as against 3.87 times previously. In recommending the issue of gift shares, the directors have recorded their intention to pay a dividend of not less than 9 per cent on the expanded capital after the proposed issue, In view of the expanding activities of the company, the authorised share capital is being increased from Rs 2 crores to Rs 3 crores.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top